Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Diabet Med ; 31(8): 941-5, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24628669

RESUMEN

AIMS: To explore insulin sensitivity and insulin secretion in people with latent autoimmune diabetes in adulthood (LADA) compared with that in people with type 2 diabetes. METHODS: A total of 12 people with LADA, defined as glutamic acid decarboxylase (GAD) antibody positivity and > 1 year of insulin independency (group A) were age-matched pairwise to people with type 2 diabetes (group B) and to six people with type 2 diabetes of similar age and BMI (group C). ß-Cell function (first-phase insulin secretion and assessment of insulin pulsatility), insulin sensitivity (hyperinsulinemic-euglycemic clamp) and metabolic response during a mixed meal were studied. RESULTS: Both first-phase insulin secretion and insulin release during the meal were greater (P = 0.05 and P = 0.009, respectively) in type 2 diabetes as compared with LADA; these differences were lost on adjustment for BMI (group C) and could be explained by BMI alone in a multivariate analysis. Neither insulin pulsatility, incretin secretion nor insulin sensitivity differed among the groups. CONCLUSIONS: We found no evidence that LADA and type 2 diabetes were distinct disease entities beyond the differences explained by BMI.


Asunto(s)
Enfermedades Autoinmunes/metabolismo , Diabetes Mellitus Tipo 1/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Resistencia a la Insulina , Células Secretoras de Insulina/metabolismo , Insulina/metabolismo , Adulto , Edad de Inicio , Autoanticuerpos/análisis , Enfermedades Autoinmunes/complicaciones , Enfermedades Autoinmunes/tratamiento farmacológico , Enfermedades Autoinmunes/epidemiología , Glucemia/análisis , Índice de Masa Corporal , Estudios de Cohortes , Estudios Transversales , Diabetes Mellitus Tipo 1/complicaciones , Diabetes Mellitus Tipo 1/tratamiento farmacológico , Diabetes Mellitus Tipo 1/epidemiología , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/complicaciones , Técnica de Clampeo de la Glucosa , Glutamato Descarboxilasa/antagonistas & inhibidores , Humanos , Hipoglucemiantes/uso terapéutico , Incretinas/sangre , Incretinas/metabolismo , Insulina/sangre , Insulina/uso terapéutico , Secreción de Insulina , Células Secretoras de Insulina/efectos de los fármacos , Análisis por Apareamiento , Obesidad/complicaciones , Sobrepeso/complicaciones , Periodo Posprandial
2.
Nutr Metab Cardiovasc Dis ; 23(7): 612-8, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22405535

RESUMEN

BACKGROUND AND AIMS: High-fat diets have become increasingly popular for weight-loss, but their effect on the oxidation potential of lipoprotein subfractions has not been studied. Therefore, this study compared the effects of high-fat vs. low-fat weight reduction diets on this parameter. METHODS AND RESULTS: Very-low, low- and high-density lipoprotein (VLDL, LDL & HDL) subfractions were isolated by rapid ultracentrifugation from 24-overweight/obese subjects randomised to a high- or low-fat diet. The lipoprotein subfractions were assessed for oxidation potential by measuring conjugated diene (CD) production and time at half maximum. We found a significant between-group difference in oxidation potential. Specifically, a high-fat diet led to increased CD production in VLDL(A-D) and HDL(2&3), and a prolongation of time at half maximum. Within-group differences found that CDs increased in VLDL(A&D), LDL(I-III) and HDL(2&3) in the high-fat group and fell in VLDL(A-C) and HDL(2&3) and increased in LDL(I&II), in the low-fat group. Furthermore, following both diets all lipoprotein subfractions, except LDL(II) in the low-fat group, were protected against oxidation. CONCLUSION: These results demonstrate that at first glance, a high-fat diet may be indicative of having heart-protective properties. However, this may be erroneous, as although the time for oxidation to occur was prolonged, once this occurred these lipoproteins had the potential to produce significantly more oxidised substrate. Conversely, a low-fat diet may be considered anti-atherogenic, as these subfractions were protected against oxidation and mainly contained fewer oxidised substrate. Thus, increased fat intake may, by increasing the oxidation product within lipoprotein subfractions, increase cardiovascular disease.


Asunto(s)
Dieta Aterogénica/efectos adversos , Dieta con Restricción de Grasas/efectos adversos , Dieta Alta en Grasa/efectos adversos , Dieta Reductora/métodos , Lipoproteínas HDL/sangre , Lipoproteínas LDL/sangre , Lipoproteínas VLDL/sangre , Adulto , Índice de Masa Corporal , Cobre/farmacología , Ácidos Grasos Insaturados/análisis , Ácidos Grasos Insaturados/química , Femenino , Humanos , Cinética , Lipoproteínas HDL/química , Lipoproteínas HDL/efectos de los fármacos , Lipoproteínas LDL/análisis , Lipoproteínas LDL/química , Lipoproteínas LDL/efectos de los fármacos , Lipoproteínas VLDL/análisis , Lipoproteínas VLDL/química , Lipoproteínas VLDL/efectos de los fármacos , Masculino , Obesidad/sangre , Obesidad/dietoterapia , Sobrepeso/sangre , Sobrepeso/dietoterapia , Oxidantes/farmacología , Oxidación-Reducción/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA